Review
Nature Reviews Genetics 7, 606-619 (August 2006) | doi:10.1038/nrg1879
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman1,2, Ji Luo1 & Lewis C. Cantley1,3 About the authors
Abstract
Phosphatidylinositol 3-kinases (PI3Ks) evolved from a single enzyme that regulates vesicle trafficking in unicellular eukaryotes into a family of enzymes that regulate cellular metabolism and growth in multicellular organisms. In this review, we examine how the PI3K pathway has evolved to control these fundamental processes, and how this pathway is in turn regulated by intricate feedback and crosstalk mechanisms. In light of the recent advances in our understanding of the function of PI3Ks in the pathogenesis of diabetes and cancer, we discuss the exciting therapeutic opportunities for targeting this pathway to treat these diseases.
- View At a Glance
Author affiliations
- Department of Systems Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA.
- Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
- Department of Systems Biology, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.
Correspondence to: Lewis C. Cantley1,3 Email: lewis_cantley@hms.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
TORward AKTually useful mouse modelsNature Medicine News and Views (01 Jun 2004)
Drugging the PI3 kinomeNature Biotechnology News and Views (01 Jul 2006)
RESEARCH
Novel active site in Escherichia coli fructose 1,6-bisphosphate aldolaseNature Structural Biology Article (01 Oct 1996)
A CD14-independent LPS receptor clusterNature Immunology Article (01 Apr 2001)
See all 25 matches for Research
